BioCentury | Sep 1, 2020
Politics, Policy & Law

Proposed CMS pathway could be expanded to give therapies, diagnostics immediate, national coverage

A medical devices reimbursement rule proposed by CMS could lay the groundwork for innovative medicines to be covered by Medicare immediately after FDA approval. The proposed rule, which applies only to...
BioCentury | Mar 15, 2019
Product Development

The microbiome universe in two maps

In its “big bang” over the last decade, the universe of microbiome therapeutics has expanded far beyond its origins of fecal transplants, used primarily for C. difficile . Mapping biotech activity reveals a broadening range of...
BioCentury | Feb 23, 2009
Clinical News

Trofile co-receptor tropism assay diagnostic data

...frequently than SensiTrop II in non-clade B samples. SensiTrop II HIV co-receptor assay is from Pathway Diagnostics Corp....
BioCentury | Feb 23, 2009
Clinical News

SensiTrop II HIV co-receptor assay diagnostic data

...Reyataz atazanavir. Data were presented at the Conference on Retroviruses and Opportunistic Infections in Montreal. Pathway Diagnostics Corp....
BioCentury | May 12, 2008
Company News

Pathway Diagnostics sales and marketing update

...uses for entry. The test replaces the original SensiTrop, which only used heteroduplex tracking technology. Pathway Diagnostics Corp....
BioCentury | Nov 5, 2007
Company News

Pathway Diagnostics, Quest Diagnostics deal

...personalize treatment. DGX hopes to launch its test in 1Q08. Further terms were not disclosed. Pathway Diagnostics Corp....
BioCentury | Oct 15, 2007
Strategy

CCR5 gatekeepers

...a choice of two companion diagnostics involving different trade-offs: SensiTrop HIV co-receptor tropism assay from Pathway Diagnostics Corp....
BioCentury | Sep 24, 2007
Company News

Pathway Diagnostics sales and marketing update

...assay in the U.S. The test determines which co-receptors the HIV virus uses for entry. Pathway Diagnostics Corp....
BioCentury | Apr 23, 2007
Tools & Techniques

Biomarking PTEN

...they are typically used in conjunction with other biomarkers and clinical data," said Sawyers. Pathway Diagnostics Corp....
BioCentury | Jan 15, 2007
Company News

Pathway Diagnostics, Qiagen sales and marketing update

...assay technology platforms and Pathway's biomarker development and testing services. Financial terms were not disclosed. Pathway Diagnostics Corp....
Items per page:
1 - 10 of 12
BioCentury | Sep 1, 2020
Politics, Policy & Law

Proposed CMS pathway could be expanded to give therapies, diagnostics immediate, national coverage

A medical devices reimbursement rule proposed by CMS could lay the groundwork for innovative medicines to be covered by Medicare immediately after FDA approval. The proposed rule, which applies only to...
BioCentury | Mar 15, 2019
Product Development

The microbiome universe in two maps

In its “big bang” over the last decade, the universe of microbiome therapeutics has expanded far beyond its origins of fecal transplants, used primarily for C. difficile . Mapping biotech activity reveals a broadening range of...
BioCentury | Feb 23, 2009
Clinical News

Trofile co-receptor tropism assay diagnostic data

...frequently than SensiTrop II in non-clade B samples. SensiTrop II HIV co-receptor assay is from Pathway Diagnostics Corp....
BioCentury | Feb 23, 2009
Clinical News

SensiTrop II HIV co-receptor assay diagnostic data

...Reyataz atazanavir. Data were presented at the Conference on Retroviruses and Opportunistic Infections in Montreal. Pathway Diagnostics Corp....
BioCentury | May 12, 2008
Company News

Pathway Diagnostics sales and marketing update

...uses for entry. The test replaces the original SensiTrop, which only used heteroduplex tracking technology. Pathway Diagnostics Corp....
BioCentury | Nov 5, 2007
Company News

Pathway Diagnostics, Quest Diagnostics deal

...personalize treatment. DGX hopes to launch its test in 1Q08. Further terms were not disclosed. Pathway Diagnostics Corp....
BioCentury | Oct 15, 2007
Strategy

CCR5 gatekeepers

...a choice of two companion diagnostics involving different trade-offs: SensiTrop HIV co-receptor tropism assay from Pathway Diagnostics Corp....
BioCentury | Sep 24, 2007
Company News

Pathway Diagnostics sales and marketing update

...assay in the U.S. The test determines which co-receptors the HIV virus uses for entry. Pathway Diagnostics Corp....
BioCentury | Apr 23, 2007
Tools & Techniques

Biomarking PTEN

...they are typically used in conjunction with other biomarkers and clinical data," said Sawyers. Pathway Diagnostics Corp....
BioCentury | Jan 15, 2007
Company News

Pathway Diagnostics, Qiagen sales and marketing update

...assay technology platforms and Pathway's biomarker development and testing services. Financial terms were not disclosed. Pathway Diagnostics Corp....
Items per page:
1 - 10 of 12